Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endovascular microneedle t-PA injection for retinal vascular occlusion
jRCTs051190021Completed
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of tissue-plasminogen activator in Vein occlusion (RVO) and Retinal Infarction. Primary endpoints: Background and medical history, Retinal vascular blood flow (fluorescein angiography) and 3 more. Started May 2017; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
Vein occlusion (RVO)Retinal Infarction
Beyond the preview
Go deeper on jRCTs051190021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190021.